Health News

OrbusNeich's COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

Author: Australian Business

SAN FRANCISCO, Oct. 29, 2013 /PRNewswire/ -- OrbusNeich today announced that new clinical data presented at TCT 2013 show durable outcomes as well as excellent early healing and optimal neointimal suppression out to 24 months following placement of the COMBO Dual Therapy Stent. These......

More...

More Articles...

DSM and Opthea Sign Agreement to Manufacture Opthea's Lead Product for Eye Disease
IlliniCare Health Plan and Aetna Better Health of Illinois Join Forces with the State of Illinois to Pilot Breast Cancer Screening and Treatment Program
Birth Defect Drugs and Pharmaceutical Lawsuits are the Topic of New Website Social-Policy.com
In Honor of Breast Cancer Awareness Month, Cakejournal.com Matches Donations from their Readers
More Than 80% of Radiologists Use Mobile Devices for Medical Imaging
National Asian Breast Cancer Initiative Launches New Campaign 'Asian Women Don't Get Breast Cancer'
Neue Richtlinien empfehlen Fidaxomicin zur Behandlung der Clostridium-Difficile-Infektion für alle Patienten, die für eine orale Verabreichung von Antibiotika infrage kommen
Volcano Announces New Two-Year Results of Largest Prospective Study of Use of IVUS in Stent Placement
Pew: Prison Health Care Spending Up Sharply in States
Local Santa Rosa Dental Practice, LehmanWaggener Professional Dental Corporation, Educates the Community through a New, Interactive Website

Page 721 of 1908

OrbusNeich's COMBO&trade; Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

More Articles...

OrbusNeich's COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months